Literature DB >> 15224125

Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude.

M Valencia-Flores1, V Rebollar, V Santiago, A Orea, C Rodríguez, M Resendiz, A Castaño, J Roblero, R M Campos, J Oseguera, G García-Ramos, D L Bliwise.   

Abstract

OBJECTIVE: To determine the point prevalence of pulmonary hypertension (PH) and its relationship with respiratory disturbances in obese patients living at moderate altitude.
SUBJECTS: A total of 57 obese patients comprised the final sample and consisted of 34 women and 23 men, with a mean age of 42.7+/-12.1 ys and a mean body mass index (BMI) 47.1+/-10.6 kg/m(2) (range from 30.1 to 76.1). The mean living altitude was 2248.7 m, range 2100-2400 m above sea level. MEASUREMENTS: Doppler echocardiography, pulmonary function tests, arterial blood gas analysis, and polysomnography were performed.
RESULTS: Data showed that 96.5% of the studied sample had daytime PH defined as calculated systolic pulmonary artery pressure (PSAP) >30 mmHg (mean PSAP=50, s.d.=13 mmHg). The severity of diurnal PH was found to be related to the presence of alveolar hypoventilation and BMI. The main risk factor for severity of diurnal PH was hypoventilation with a significant odds ratio (OR) 7.96, 95% CI 1.35-46.84, BMI was (OR 1.12, 95% CI 1.02-1.25) and apnea/hypopnea index was not a predictor of pulmonary hypertension severity (OR 0.99, 95% CI 0.97-1.02).
CONCLUSION: We concluded that prevalence of diurnal PH is high in obese patients living at moderate altitude, and that hypoventilation is the main risk factor associated with the severity of pulmonary hypertension.

Entities:  

Mesh:

Year:  2004        PMID: 15224125     DOI: 10.1038/sj.ijo.0802726

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  9 in total

1.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

2.  Right ventricular geometry and mechanics in patients with obstructive sleep apnea living at high altitude.

Authors:  Tolga Sinan Güvenç; Nergiz Hüseyinoğlu; Serkan Özben; Şeref Kul; Rengin Çetin; Kaya Özen; Coşkun Doğan; Bahattin Balci
Journal:  Sleep Breath       Date:  2015-04-19       Impact factor: 2.816

Review 3.  Obesity as a Conditioning Factor for High-Altitude Diseases.

Authors:  Rocío San Martin; Julio Brito; Patricia Siques; Fabiola León-Velarde
Journal:  Obes Facts       Date:  2017-08-16       Impact factor: 3.942

4.  Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study.

Authors:  Marcela Rodríguez-Flores; Eduardo García-García; Claudia Vanessa Cano-Nigenda; Carlos Cantú-Brito
Journal:  Cardiovasc Diabetol       Date:  2014-01-03       Impact factor: 9.951

5.  Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice.

Authors:  Balram Neupane; Akylbek Sydykov; Kabita Pradhan; Christina Vroom; Christiane Herden; Srikanth Karnati; Hossein Ardeschir Ghofrani; Sergey Avdeev; Süleyman Ergün; Ralph Theo Schermuly; Djuro Kosanovic
Journal:  Respir Res       Date:  2020-06-03

6.  The Association of Body Mass Index With the Risk of Pulmonary Hypertension in Adults: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Shoufang Pu; Lidan Yin; Bi Wen; Juan He
Journal:  Front Med (Lausanne)       Date:  2022-01-25

7.  Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms.

Authors:  Scott E Friedman; Bruce W Andrus
Journal:  J Obes       Date:  2012-09-03

8.  Therapeutic Use of Exercising in Hypoxia: Promises and Limitations.

Authors:  Gregoire P Millet; Tadej Debevec; Franck Brocherie; Davide Malatesta; Olivier Girard
Journal:  Front Physiol       Date:  2016-06-10       Impact factor: 4.566

9.  Evaluation of right ventricular performance and impact of continuous positive airway pressure therapy in patients with obstructive sleep apnea living at high altitude.

Authors:  Ai-Ai Chu; Hong-Mei Yu; Hui Yang; Li-Min Tian; Zhong-Yuan Hu; Na Jiang; Wan-Xia Xie; Yan Huang
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.